Seeking men and women who have had a bone marrow transplant and have an upper respiratory tract infection caused by respiratory syncytial virus (RSV) for a study of an investigational drug.
Participants in this study will receive either the investigational drug or a placebo (looks like the drug but contains no medicine).
What we're hoping for
We are studying whether the investigational drug shortens the length of an upper respiratory infection from Respiratory Syncytial Virus (RSV) in people who have had a bone marrow transplant.
ClinicalTrials.gov Identifier: NCT04267822